What “healthspan” is when you refuse to let it collapse onto mortality or disease. The wiki centres a health axis that includes function and healthspan, not only length of life (Rating Outcome Importance). This page holds the construct that operationalizes that axis as a measurable, person-centred functional outcome — so that “does this lever extend healthspan?” is a question with an answerable endpoint rather than a slogan.

The construct — two person-centred functional measures, not a biomarker

(Zheng et al., 2026) Healthspan is chronically underspecified — a recent review counted more than 100 definitions, and the most common (multimorbidity) is disease-centred. Zheng’s SR deliberately takes the alternative route: measures with «a person-centered focus on functioning rather than diagnoses».

  • Intrinsic capacity (IC) — «the sum of an individual’s physical and mental abili­ties… proposed as an integrated measure of health­span»; a WHO composite of 5 domains — cognition, locomotion, vitality, psychological, sensory — scored objectively. «Rather than a disease lens, IC focuses on the capacity of individuals to maintain good health».
  • Quality of life (QoL) — a multidimensional indicator of self-perceived well-being; the subjective complement to IC’s objective tests (SF-36, EQ-5D, and others in the included trials).
  • The construct claim: «a composite IC score would serve as a better indicator when assessing healthspan instead of single domains of IC (e.g., locomotion or cognitive domain alone)» — the whole is held to carry more than any one domain.

Why the composite matters for the outcome menu (the anti-streetlight point)

(inferred from Zheng et al., 2026) This is the outcome-menu architecture made concrete. A composite person-centred function score is an anti-streetlight device on the outcome side: it resists redefining “health” as whatever single, well-lit endpoint a trial happened to measure (a lab marker, a single cognitive test, a disease event). It is the positive-capacity mirror of Frailty — frailty measures reduced reserve / deficit accumulation; IC measures the remaining integrated ability — the two are complementary lenses on the same aging-function axis, not duplicates (frailty is deficit-defined; IC is capacity-defined).

  • But the same measures are the ones the field measures WORST. QoL and self-rated function are self-reported and heterogeneous across scales — exactly the outcomes CLAUDE.md flags for more honest uncertainty, not more confident advice. Zheng’s own caveat confirms it: «self-reported data tend to overestimate the effects due to reporting bias in RCTs», compounded by the inability to blind exercise/cognitive interventions and by a Hawthorne effect. So a composite-function benefit on self-report is discounted, not taken at face value. (Zheng et al., 2026)

What moves it — the hedged evidence (single 2026 SR, recency-discounted)

(Zheng et al., 2026) 15 RCTs, 4656 participants, no meta-analysis (too heterogeneous — qualitative synthesis only). The one signal that survives the heterogeneity is exercise:

  • «there is some evidence that exercise could extend intrinsic capacity and quality of life, either aer­obic or resistance training alone, or a combination of different types of exercise; but further research is required to evaluate the effect of other interventions» — the exercise signal is reported in 11 of 13 exercise/multidomain studies; the «further research» caveat attaches to the other (non-exercise) interventions, not to the exercise finding. But even the exercise effect is small: «the effect sizes were generally small, and therefore, the clinical significance of these differen­ces is unclear».
  • The multidomain effect is probably the exercise component. All 6 multidomain trials included exercise; «none of the included studies investigated cognitive training or nutrition alone… the protective effect of multidomain inter­ventions on IC and QoL may be predominantly due to the exercise component». So this is not independent support for cognitive-training or nutrition levers.
  • Everything else is insufficient-evidence, not no-effect. Caloric restriction (1 study: 25% CR over 2 yr, SF-36 QoL +6.45 [3.93, 8.98]) and NMN supplementation (1 study) each showed an effect but rest on n=1; omega-3 alone was null. «no conclusion could be drawn regarding other interventions.»

Confidence: low, and recency-guarded. A single 2026 SR in a nascent, fast-moving field (the authors note multiple IC-focused trials reporting within 2-3 years) carries a lower prior of being the settled truth, per the crowded-field recency rule. Treat the exercise -> IC/QoL direction as directionally supported, magnitude small and uncertain, not established. (inferred from Zheng et al., 2026)

Decision relevance and transportability

(inferred from Zheng et al., 2026)

  • No new lever, a second outcome on a lever already ranked high. Exercise is already a big rock for mortality and function (Physical Activity Dose and Mortality, Muscle-Strengthening Activity and Mortality); IC/QoL is a further patient-important outcome it moves, not a free-standing new intervention. The RCT bundle evidence for the cognitive slice of IC is developed separately and is weak/unreplicated -> Multidomain Lifestyle Intervention and Cognitive Decline (do not read that page’s cognitive-surrogate nulls as evidence about the whole IC composite — different endpoint).
  • Healthy-user selection bounds transport. «due to the nature of exercise-related interventions, many studies excluded individu­als with contraindications to physical activity… participants in these trials had better baseline health conditions than their peers» — so the estimates come from a healthier-than-average older stratum, and evidence «may be generalized to older Caucasians and Asians from high-income or upper-middle in­come countries», not younger or lower-income populations. (Zheng et al., 2026)

Open (G-gaps)

  • A magnitude the SR structurally cannot give — no pooled effect size for exercise -> IC/QoL (no meta-analysis; heterogeneous scales). G (needs aggregation). Zheng flags multiple IC-focused RCTs underway (results expected 2-3 yr) that «will allow further quantitative synthesis» — a future meta-analysis, not a source held or yet registered, so no [AWAITS] handle is set.
  • Component isolation — is any non-exercise multidomain component (cognitive training, nutrition) an independent IC/QoL lever? Untested (none studied alone).
  • Does moving IC/QoL move hard outcomes? IC/QoL are the person-centred targets, but the causal link from a composite-function gain to survival or disability-free years is unproven here -> Surrogate Outcomes.

References

Zheng, H. T., Phyo, A. Z. Z., McCubbin, C., Wu, Z., Bischoff-Ferrari, H. A., & Ryan, J. (2026). Interventions that prolong multidimensional healthspan in humans: a systematic review of randomized controlled trials. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 81(7). https://doi.org/10.1093/gerona/glag133